Alkem Laboratories (NSE:ALKEM) E10: ₹138.47 (As of Mar. 2026)


NSE:ALKEM Alkem Laboratories Ltd NSE:ALKEM
96 GF Score
Price ₹5,425.00
GF Value ₹6,066.47
Valuation Modestly Undervalued
! 1 Warning Sign
View Full Analysis

What is Alkem Laboratories E10?

Alkem Laboratories NSE:ALKEM -0.06% 96 E10 is ₹138.47 as of Mar. 2026. GuruFocus rates NSE:ALKEM with a GF Score™ of 96/100 and a GF Value™ of ₹6,066.47 (Modestly Undervalued). The stock has 1 warning sign investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Alkem Laboratories's adjusted earnings per share data for the three months ended in Mar. 2026 was ₹19.770. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is ₹138.47 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Alkem Laboratories's average E10 Growth Rate was 11.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2026-06-27), Alkem Laboratories's current stock price is ₹5425.00. Alkem Laboratories's E10 for the quarter that ended in Mar. 2026 was ₹138.47. Alkem Laboratories's Shiller PE Ratio of today is 39.18.

During the past 13 years, the highest Shiller PE Ratio of Alkem Laboratories was 54.99. The lowest was 32.36. And the median was 41.68.


Alkem Laboratories  (NSE:ALKEM) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Alkem Laboratories's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=5425.00/138.47
=39.18

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Alkem Laboratories was 54.99. The lowest was 32.36. And the median was 41.68.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Alkem Laboratories E10 Related Terms


Alkem Laboratories E10 Historical Data

* Premium members only.

The historical data trend for Alkem Laboratories's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Alkem Laboratories E10 Chart

Alkem Laboratories Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 112.01 123.70 138.47

Alkem Laboratories Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 123.70 128.29 133.17 136.82 138.47

NSE:ALKEM vs ZTS: E10 Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Alkem Laboratories's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Alkem Laboratories Shiller PE Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Alkem Laboratories's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Alkem Laboratories's Shiller PE Ratio falls into.


NSE:ALKEM
96GF Score
Alkem Laboratories Ltd NSE:ALKEM
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Alkem Laboratories E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Alkem Laboratories's adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=19.77/164.2724*164.2724
=19.770

Current CPI (Mar. 2026) = 164.2724.

Alkem Laboratories Quarterly Data

per share eps CPI Adj_EPS
201606 19.970 105.961 30.960
201609 23.650 105.961 36.665
201612 19.520 105.196 30.482
201703 11.460 105.196 17.896
201706 5.990 107.109 9.187
201709 26.820 109.021 40.412
201712 14.360 109.404 21.562
201803 5.610 109.786 8.394
201806 11.390 111.317 16.808
201809 21.280 115.142 30.360
201812 16.940 115.142 24.168
201903 14.000 118.202 19.457
201906 15.510 120.880 21.078
201909 31.020 123.175 41.370
201912 31.950 126.235 41.577
202003 15.780 124.705 20.787
202006 35.300 127.000 45.660
202009 39.480 130.118 49.843
202012 37.720 130.889 47.340
202103 20.080 131.771 25.033
202106 39.150 134.084 47.964
202109 45.520 135.847 55.045
202112 43.960 138.161 52.268
202203 8.990 138.822 10.638
202206 10.680 142.347 12.325
202209 27.670 144.661 31.421
202212 38.030 145.763 42.859
202303 5.930 146.865 6.633
202306 23.980 150.280 26.213
202309 51.900 151.492 56.278
202312 49.760 152.924 53.453
202403 24.550 153.035 26.353
202406 45.600 155.789 48.083
202409 57.600 157.882 59.931
202412 52.340 158.323 54.307
202503 25.570 157.552 26.661
202506 55.560 159.755 57.131
202509 63.990 162.289 64.772
202512 53.190 163.281 53.513
202603 19.770 164.272 19.770

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of ₹138.47 mean?
Alkem Laboratories (NSE:ALKEM) has a E10 of ₹138.47 as of Mar. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Alkem Laboratories and its competitors.
Is Alkem Laboratories' E10 too high?
Alkem Laboratories' current E10 is ₹138.47. Overall, Alkem Laboratories has a GF Score™ of 96/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Alkem Laboratories' E10 compare to ZTS?
Alkem Laboratories' E10 of ₹138.47 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Drug Manufacturers company?
A good E10 depends on the Drug Manufacturers industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Alkem Laboratories and its competitors. Alkem Laboratories's current E10 is ₹138.47. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alkem Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Alkem Laboratories (NSE:ALKEM) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹6,066.47, compared to a current price of ₹5,425.00 — trading 10.6% below its estimated fair value. The current E10 is ₹138.47. Alkem Laboratories' overall GF Score™ is 96/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Alkem Laboratories (NSE:ALKEM), the current E10 is ₹138.47 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Alkem Laboratories (NSE:ALKEM) Overvalued in 2026?

Based on GuruFocus' analysis, Alkem Laboratories stock appears to be undervalued. The current stock price of ₹5,425.00 is trading 10.6% below its estimated GF Value™ of ₹6,066.47. GuruFocus considers Alkem Laboratories to be Modestly Undervalued.

Key valuation signals for NSE:ALKEM:

  • E10: ₹138.47
  • GF Value™: ₹6,066.47 vs. price of ₹5,425.00 (10.6% below fair value)
  • GF Score™: 96/100 with 1 warning sign

No single metric tells the full story. See the NSE:ALKEM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Alkem Laboratories Business Description

Other Exchanges 539523:India
Address Senapati Bapat Marg, Alkem House, Devashish Building, Lower Parel, Mumbai, MH, IND, 400 013
Alkem Laboratories Ltd is an Indian pharmaceutical company engaged in the development, manufacture, and sale of pharmaceutical and nutraceutical products. The company produces branded generics, generic drugs, active pharmaceutical ingredients (APIs) and nutraceuticals in acute and chronic therapeutic areas, such as anti-infective, pain and analgesics, vitamins/minerals/nutrients, cardiac and Diabetology, Gynecology, neuro/central nervous system, dermatology, anti-diabetes, anti-osteoporosis, cardiovascular, and muscle relaxants, which are marketed in Indian and International markets. It operates through the pharmaceutical business segment.
96GF Score

Get the complete analysis for NSE:ALKEM

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹5,425.00
Price
₹6,066.47
GF Value